Evaluation of IL 12B Genetic Polymorphism (rs3213094)

ConditionPsoriasis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSouth Valley University

About this trial

Psoriasis is a skin disorder that is chronic proliferative and inflammatory in nature. Extensor surfaces, scalp, and lumbosacral area are covered in erythematous plaques with silvery scales. The disease can also impair the eyes and joints. It has no cure. Because of their low quality of life, many psoriasis patients experience depression. In addition to the cutaneous manifestations, it is associated with an increased risk of psoriatic arthritis, depression and cardiovascular disease.

Eligibility criteria

Qualifiers

None

Disqualifiers

Patients with other autoimmune or inflammatory conditions (e.g., rheumatoid arthritis, lupus).

Pregnancy and lactation.

Patients currently undergoing any treatment other than Humira.

Patients with known genetic disorders affect immune system function.

Trial design

Treatments tested in this trial

  • Humira

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators